Related Experiment Video

Updated: May 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Proposed mechanisms of action for prostate cancer vaccines

Sean M Geary1, Caitlin D Lemke, David M Lubaroff

  • 1Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.

Nature Reviews. Urology
|February 13, 2013
PubMed

Insights

Prostate cancer vaccines show promise for treating metastatic disease by harnessing the patient's immune system. Future strategies may involve targeting regulatory T lymphocytes to improve treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapy

Background:

  • Prostate cancer causes significant mortality, with no cure for metastatic stages.
  • Chemotherapy and radical prostatectomy have limitations for advanced disease.
  • Alternative therapies, including cancer vaccines, are under investigation.

Purpose of the Study:

  • To explore the potential of prostate cancer vaccines as an alternative therapy.
  • To investigate factors influencing vaccine efficacy, such as disease stage and adjuvant therapies.
  • To examine strategies for modulating regulatory T lymphocytes in prostate cancer treatment.

Main Methods:

  • Clinical trials investigating prostate cancer vaccines.
  • Analysis of immune responses, specifically cytotoxic T lymphocyte activity.
  • Evaluation of disease progression and treatment parameters.

Main Results:

  • Prostate cancer vaccines have demonstrated modest but encouraging clinical trial results.
  • The immune system can be stimulated to attack tumors via vaccine-mediated T cell responses.
  • Understanding influencing factors is crucial for optimizing vaccine therapy.

Conclusions:

  • Prostate cancer vaccines represent a promising therapeutic avenue for advanced disease.
  • Optimizing vaccine strategies requires careful consideration of disease stage and immune modulation.
  • Targeting regulatory T lymphocytes is a key area for future research in prostate cancer immunotherapy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...